Comparative costs and activity from a sample of UK clinical trials units
Autor: | Christopher Bray, Nicola Keat, Lynda Harper, Chris Speed, Christopher Hayward, Barnaby C Reeves, Andrea Corkhill, Liz Tremain, Sarah Bathers, Vicky Napp, John Norrie, Mike Bradburn, Daniel Hind |
---|---|
Rok vydání: | 2017 |
Předmět: |
Budgets
Research design Cost Control Cost-Benefit Analysis Medicine (miscellaneous) Sample (statistics) BTC (Bristol Trials Centre) 03 medical and health sciences Indirect costs 0302 clinical medicine Research Support as Topic Economic cost Journal Article Humans Multicenter Studies as Topic Pharmacology (medical) Operations management Staff Cost 030212 general & internal medicine Clinical Trial Unit Randomized Controlled Trials as Topic Protocol (science) lcsh:R5-920 Cost–benefit analysis Indirect Cost Research United Kingdom Grant Application Central Monitoring Research Design Centre for Surgical Research 030220 oncology & carcinogenesis Thematic analysis Full-time equivalent lcsh:Medicine (General) Psychology |
Zdroj: | Hind, D, Reeves, B, Bathers, S, Bray, C, Corkhill, A, Hayward, C, Harper, L, Napp, V, Norrie, J, Speed, C, Treamain, L, Keat, N & Bradburn, M J 2017, ' Comparative costs and activity from a sample of UK clinical trials units ', Trials, vol. 18, 203 . https://doi.org/10.1186/s13063-017-1934-3 Hind, D, Reeves, B C, Bathers, S, Bray, C, Corkhill, A, Hayward, C, Harper, L, Napp, V, Norrie, J, Speed, C, Tremain, L, Keat, N & Bradburn, M 2017, ' Comparative costs and activity from a sample of UK clinical trials units ', Trials, vol. 18, no. 1, pp. 203 . https://doi.org/10.1186/s13063-017-1934-3 Trials Trials, Vol 18, Iss 1, Pp 1-11 (2017) |
ISSN: | 1745-6215 |
Popis: | Background The costs of medical research are a concern. Clinical Trials Units (CTUs) need to better understand variations in the costs of their activities. Methods Representatives of ten CTUs and two grant-awarding bodies pooled their experiences in discussions over 1.5 years. Five of the CTUs provided estimates of, and written justification for, costs associated with CTU activities required to implement an identical protocol. The protocol described a 5.5-year, nonpharmacological randomized controlled trial (RCT) conducted at 20 centres. Direct and indirect costs, the number of full time equivalents (FTEs) and the FTEs attracting overheads were compared and qualitative methods (unstructured interviews and thematic analysis) were used to interpret the results. Four members of the group (funding-body representatives or award panel members) reviewed the justification statements for transparency and information content. Separately, 163 activities common to trials were assigned to roles used by nine CTUs; the consistency of role delineation was assessed by Cohen’s κ. Results Median full economic cost of CTU activities was £769,637 (range: £661,112 to £1,383,323). Indirect costs varied considerably, accounting for between 15% and 59% (median 35%) of the full economic cost of the grant. Excluding one CTU, which used external statisticians, the total number of FTEs ranged from 2.0 to 3.0; total FTEs attracting overheads ranged from 0.3 to 2.0. Variation in directly incurred staff costs depended on whether CTUs: supported particular roles from core funding rather than grants; opted not to cost certain activities into the grant; assigned clerical or data management tasks to research or administrative staff; employed extensive on-site monitoring strategies (also the main source of variation in non-staff costs). Funders preferred written justifications of costs that described both FTEs and indicative tasks for funded roles, with itemised non-staff costs. Consistency in role delineation was fair (κ = 0.21–0.40) for statisticians/data managers and poor for other roles (κ |
Databáze: | OpenAIRE |
Externí odkaz: |